Blasenkarzinom: Perioperative Komplikationen nach neoadjuvantem Pembrolizumab
- PMID: 33822342
- DOI: 10.1055/a-1257-9582
Blasenkarzinom: Perioperative Komplikationen nach neoadjuvantem Pembrolizumab
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Comment on
-
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial.Eur Urol. 2020 May;77(5):576-580. doi: 10.1016/j.eururo.2019.12.019. Epub 2020 Jan 3. Eur Urol. 2020. PMID: 31911010
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
